Tyra Biosciences (TYRA) Shares Outstanding (Weighted Average) (2020 - 2026)

Tyra Biosciences has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $61.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 4.06% year-over-year to $61.7 million; the trailing twelve-month figure through Mar 2026 stood at $61.7 million (up 4.06% YoY), and the FY2025 full-year result was $59.6 million, up 4.11% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $61.7 million, up from $6.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $61.7 million in Q1 2026, with the low at $6.4 million in Q4 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $47.8 million across 5 years, with a median of $42.9 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) soared 1967.9% — and 2025, when it sank 88.85%.
• Tyra Biosciences' Shares Outstanding (Weighted Average) stood at $42.6 million in 2022, then advanced by 0.6% to $42.9 million in 2023, then soared by 33.5% to $57.3 million in 2024, then slumped by 88.85% to $6.4 million in 2025, then soared by 867.51% to $61.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $61.7 million (Q1 2026), $6.4 million (Q4 2025), and $59.5 million (Q3 2025), per Business Quant data.